BE852283A - Compositions carcinostatiques et leur utilisation - Google Patents

Compositions carcinostatiques et leur utilisation

Info

Publication number
BE852283A
BE852283A BE175645A BE175645A BE852283A BE 852283 A BE852283 A BE 852283A BE 175645 A BE175645 A BE 175645A BE 175645 A BE175645 A BE 175645A BE 852283 A BE852283 A BE 852283A
Authority
BE
Belgium
Prior art keywords
carcinostatic
compositions
carcinostatic compositions
Prior art date
Application number
BE175645A
Other languages
English (en)
Original Assignee
Rikagaku Kenkyusho & Kochi Mut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rikagaku Kenkyusho & Kochi Mut filed Critical Rikagaku Kenkyusho & Kochi Mut
Publication of BE852283A publication Critical patent/BE852283A/fr

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nanotechnology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE175645A 1976-03-09 1977-03-09 Compositions carcinostatiques et leur utilisation BE852283A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2522576A JPS52108027A (en) 1976-03-09 1976-03-09 Anticarcinogen

Publications (1)

Publication Number Publication Date
BE852283A true BE852283A (fr) 1977-09-09

Family

ID=12160014

Family Applications (1)

Application Number Title Priority Date Filing Date
BE175645A BE852283A (fr) 1976-03-09 1977-03-09 Compositions carcinostatiques et leur utilisation

Country Status (9)

Country Link
US (1) US4983636A (fr)
JP (1) JPS52108027A (fr)
AU (1) AU499475B2 (fr)
BE (1) BE852283A (fr)
CA (1) CA1093971A (fr)
DE (1) DE2710327C3 (fr)
FR (1) FR2343475A1 (fr)
GB (1) GB1573965A (fr)
NL (1) NL172917C (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5446001U (fr) * 1977-09-07 1979-03-30
JPS5830032B2 (ja) * 1981-02-18 1983-06-27 呉羽化学工業株式会社 ビフイダス菌の増殖剤
JPS6112623A (ja) * 1984-06-28 1986-01-21 Kaken Pharmaceut Co Ltd エンケフアリナ−ゼ阻害剤
JPS6256423A (ja) * 1985-09-06 1987-03-12 Kaken Pharmaceut Co Ltd 悪液質治療改善剤
GB8705780D0 (en) * 1987-03-11 1987-04-15 Norsk Hydro As Anticancer compounds
AT393221B (de) * 1988-02-03 1991-09-10 Leopold Pharma Gmbh Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken
JPH0269540A (ja) * 1988-09-05 1990-03-08 Chisso Corp 結晶性ポリオレフイン組成物
US5330744A (en) * 1988-11-14 1994-07-19 Sloan-Kettering Institute For Cancer Research Method for increasing sensitivity to chemically induced terminal differentiation
US5180716A (en) * 1990-08-01 1993-01-19 The Regents Of The University Of California Cyclodextrin complexes for neuraxial administration of drugs
US5789189A (en) * 1993-09-24 1998-08-04 The Regents Of The University Of California Inhibition of cyst formation by cytoskeletal specific drugs
FR2731585B1 (fr) * 1995-03-13 2003-02-28 Stepan Co Procedes et compositions pour la desinfection des surfaces comportant des bacteries responsables de la tuberculose
EP1231919B1 (fr) 1999-09-08 2015-09-30 Sloan-Kettering Institute For Cancer Research Derivés de 1-amino-1-(hétero)arylaminocarbonyl-6-hydroxyaminocarbonylhexan utiles dans le traitement de tumeurs
TWI242015B (en) 1999-11-29 2005-10-21 Akzo Nobel Nv 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
WO2002078451A1 (fr) * 2001-03-30 2002-10-10 Premier Botanicals Ltd. Compositions pesticides obtenues a partir du prunus
AU2004228011A1 (en) * 2003-04-01 2004-10-21 Memorial Sloan-Kettering Cancer Center Hydroxamic acid compounds and methods of use thereof
JP6898072B2 (ja) * 2015-08-27 2021-07-07 秀行 佐谷 １４−３−３タンパク質活性調節剤
JP7054085B2 (ja) * 2016-06-30 2022-04-13 Ｓｈｉｏｄａライフサイエンス株式会社 バラ科サクラ属に属する植物の葉の抽出液を含有する抗腫瘍剤
JP6541087B1 (ja) * 2018-10-16 2019-07-10 株式会社ワールドナッツ アーモンドペースト組成物
JP7018531B1 (ja) * 2021-04-30 2022-02-10 潤 齋藤 Ａｘｌ阻害剤

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2827452A (en) * 1955-05-31 1958-03-18 Univ Minnesota Stabilization of materials

Also Published As

Publication number Publication date
GB1573965A (en) 1980-08-28
FR2343475B1 (fr) 1980-04-25
NL7702535A (nl) 1977-09-13
US4983636A (en) 1991-01-08
JPS54962B2 (fr) 1979-01-18
DE2710327C3 (de) 1981-02-12
DE2710327A1 (de) 1977-09-15
NL172917C (nl) 1983-11-16
FR2343475A1 (fr) 1977-10-07
AU499475B2 (en) 1979-04-26
JPS52108027A (en) 1977-09-10
AU2307377A (en) 1978-09-14
NL172917B (nl) 1983-06-16
DE2710327B2 (de) 1980-04-17
CA1093971A (fr) 1981-01-20

Similar Documents

Publication Publication Date Title
IT1078383B (it) Sci
FR2351142A1 (fr) Copolyesters ramifies et leur preparation
BE866005A (fr) Agents retardant l'inflammation et leur utilisation
BE861224A (fr) Esters steroidiques, leur preparation et leur utilisation
BE852283A (fr) Compositions carcinostatiques et leur utilisation
BE860606A (fr) Alliages de nickel-mischmetal-calcium et leur utilisation
SE7703484L (sv) Laddningskopplade kretsar och anordningar
BE847396A (fr) Alkoxysilanes et leur preparation,
FR2325635A1 (fr) N-alkyldiphenylamines et leur utilisation comme rodonticides
BE824861A (fr) Compositions anti-inflammatoires et leur utilisation
IT1094500B (it) Sci
BE855992A (fr) Inhibiteurs de testoterone 5 alpha-reductase, leur preparation et leur utilisation
BE871807A (fr) 4-quinolyl-guanidines, leur preparation et leur utilisation
PL202070A1 (pl) Regal oraz zespol regalow
BE841797A (fr) Compositions photosensibles et leur application
BE863702A (fr) Tetrazolylcarbamoylquinoleines et leur preparation
BE859221A (fr) Bis-carbamoylsulfures n-substitues et leur preparation
BE838833A (fr) Composes 3-acyloxymethyl-cephemes, leur preparation et leur utilisation
BE882010A (fr) Tetrahydrobenzothiazolylimidazolidinones et leur utilisation
BE869352A (fr) Nouvelles nitrosourees et leur application
DK408577A (da) Indgivelsessaet
BE825039A (fr) Leuco-colorants d'indolyl-methylene, leur preparation et leur utilisation
BE844029A (fr) Diepoxy-androstanes et leur preparation
BE850552A (fr) 2-furanones et leur preparation
BE830238A (fr) Compositions antiparkinsoniennes et leur utilisation

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: RIKAGAKU KENKYUSHO & KOCHI MUTSUYUKI

Effective date: 19910331